CML TKIs – where are we up to? Steve O’Brien Northern Institute for Cancer Research Newcastle University Medical School Newcastle, March 2013 Second generation TKIs are…
H. Lundbeck A/S Efficacy Data in regulatory settings, DSBS January, May 2013 H. Lundbeck A/S * Outline Part 1: Objectives and Endpoints in test strategies Part 2: Integrated…
H. Lundbeck A/S Efficacy Data in regulatory settings, DSBS January, May 2013 H. Lundbeck A/S * Outline Part 1: Objectives and Endpoints in test strategies Part 2: Integrated…